How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.
Tonya Austin, insider at AtriCure

Tonya Austin Insider Information

Insider of AtriCure
Tonya Austin joined AtriCure in May, 2013. She is responsible for all aspects of the company’s global human resources functions including organizational development, employee relations, recruitment, benefits & compensation, performance management, and talent development.   Prior to this, she held several HR leadership roles including an HR Business Partner at Endo Pharmaceuticals, Vice President of Human Resources at Vital Images Inc., and various recruitment/human resource roles at Parametric Technology Corporation (PTC) and PricewatershouseCoopers (PwC).  She graduated from the College of St. Benedict’s in St. Joseph, MN and holds a Senior Professional in Human Resources (SPHR) certification.

What is Tonya Austin's net worth?

The estimated net worth of Tonya Austin is at least $748,716.29 as of May 13th, 2022. Ms. Austin owns 17,621 shares of AtriCure stock worth more than $748,716 as of May 17th. This net worth approximation does not reflect any other assets that Ms. Austin may own. Learn More about Tonya Austin's net worth.

How old is Tonya Austin?

Ms. Austin is currently 50 years old. There are 6 older executives and no younger executives at AtriCure. The oldest executive at AtriCure is Mr. Douglas J. Seith, Chief Operating Officer, who is 56 years old. Learn More on Tonya Austin's age.

How do I contact Tonya Austin?

The corporate mailing address for Ms. Austin and other AtriCure executives is 7555 INNOVATION WAY, MASON OH, 45040. AtriCure can also be reached via phone at (513) 755-4100 and via email at [email protected] Learn More on Tonya Austin's contact information.

Has Tonya Austin been buying or selling shares of AtriCure?

Over the course of the past ninety days, Tonya Austin has sold $154,104.45 in AtriCure stock. Most recently, Tonya Austin sold 3,203 shares of the business's stock in a transaction on Friday, May 13th. The shares were sold at an average price of $42.69, for a transaction totalling $136,736.07. Following the completion of the sale, the insider now directly owns 17,621 shares of the company's stock, valued at $752,240.49. Learn More on Tonya Austin's trading history.

Who are AtriCure's active insiders?

AtriCure's insider roster includes Tonya Austin (Insider), Mark Collar (Director), Vinayak Doraiswamy (Insider), Scott Drake (Director), Regina Groves (Director), David Grumhaus, Jr. (Portfolio Manager), Justin Noznesky (Insider), Salvatore Privitera (Insider), Douglas Seith (COO), Sven Wehrwein (Director), and Angela Wirick (CFO). Learn More on AtriCure's active insiders.

Are insiders buying or selling shares of AtriCure?

During the last year, insiders at the medical device company sold shares 27 times. They sold a total of 125,795 shares worth more than $9,560,358.37. The most recent insider tranaction occured on May, 13th when insider Tonya Austin sold 3,203 shares worth more than $136,736.07. Insiders at AtriCure own 2.8 % of the company. Learn More about insider trades at AtriCure.

Information on this page was last updated on 5/13/2022.

Tonya Austin Insider Trading History at AtriCure

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2022Sell3,203$42.69$136,736.0717,621View SEC Filing Icon  
4/8/2022Sell282$61.59$17,368.3820,824View SEC Filing Icon  
3/4/2022Sell1,409$67.66$95,332.94View SEC Filing Icon  
3/2/2022Sell1,626$69.31$112,698.06View SEC Filing Icon  
2/11/2022Sell2,490$67.97$169,245.30View SEC Filing Icon  
1/14/2022Sell2,719$66.11$179,753.09View SEC Filing Icon  
12/10/2021Sell1,528$70.88$108,304.64View SEC Filing Icon  
11/12/2021Sell2,732$78.55$214,598.60View SEC Filing Icon  
10/8/2021Sell665$71.80$47,747.00View SEC Filing Icon  
9/10/2021Sell1,227$77.18$94,699.8630,333View SEC Filing Icon  
8/13/2021Sell3,232$73.10$236,259.2031,560View SEC Filing Icon  
7/16/2021Sell493$78.03$38,468.79View SEC Filing Icon  
6/18/2021Sell2,620$76.36$200,063.2035,092View SEC Filing Icon  
See Full Table

Tonya Austin Buying and Selling Activity at AtriCure

This chart shows Tonya Austin's buying and selling at AtriCure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AtriCure Company Overview

AtriCure logo
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Read More

Today's Range

Now: $42.49
Low: $42.24
High: $43.06

50 Day Range

MA: $57.73
Low: $39.59
High: $66.36

2 Week Range

Now: $42.49
Low: $38.64
High: $89.18

Volume

3,972 shs

Average Volume

334,465 shs

Market Capitalization

$1.97 billion

P/E Ratio

37.94

Dividend Yield

N/A

Beta

1.19
High Arch Potential Stock
If you're looking for a hot new sector, watch this stock closely.
Click for ticker & full details